David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.87% |
| 2 | Consumer Discretionary | 9.92% |
| 3 | Healthcare | 7.34% |
| 4 | Financials | 7.06% |
| 5 | Communication Services | 6.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Biogen
BIIB
$32B
| $107M | 0.1% |
376,491
-413,202
| -52% | -$135M |
|
202
MetLife
MET
$60B
| $107M | 0.1% |
1,725,403
+1,017,932
| +144% | +$61.3M |
|
203
Cloudflare
NET
$104B
| $106M | 0.1% |
945,279
+203,409
| +27% | +$24.3M |
|
204
Spotify
SPOT
$110B
| $106M | 0.1% |
471,468
+288,928
| +158% | +$68.1M |
|
|
205
CALL
Apple
AAPL
$4.51T
| $106M | 0.1% |
749,900
-210,900
| -22% | -$31M |
|
206
Stanley Black & Decker
SWK
$15.1B
| $106M | 0.1% |
603,912
-17,489
| -3% | -$3.41M |
|
207
PUT
HubSpot
HUBS
$12B
| $105M | 0.1% |
156,000
+51,000
| +49% | +$32.9M |
|
208
CALL
Visa
V
$693B
| $105M | 0.1% |
472,500
-28,200
| -6% | -$6.61M |
|
209
CALL
ExxonMobil
XOM
$679B
| $105M | 0.1% |
1,789,100
+142,000
| +9% | +$8.09M |
|
210
Lyft
LYFT
$6.61B
| $105M | 0.09% |
1,961,558
+417,046
| +27% | +$22.1M |
|
211
Lockheed Martin
LMT
$130B
| $105M | 0.09% |
303,860
-119,581
| -28% | -$43.3M |
|
|
DOCU
212
PUT
DocuSign
DOCU
$11.8B
| $104M | 0.09% |
405,900
-6,000
| -1% | -$1.73M |
|
213
Range Resources
RRC
$9.59B
| $104M | 0.09% |
4,605,708
+20,254
| +0.4% | +$328K |
|
214
Regeneron Pharmaceuticals
REGN
$85.9B
| $104M | 0.09% |
172,135
+119,119
| +225% | +$74M |
|
215
PUT
ASML
ASML
$677B
| $104M | 0.09% |
139,500
+61,800
| +80% | +$48.6M |
|
|
DISCK
216
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $104M | 0.09% |
4,271,354
-1,423,033
| -25% | -$38M |
|
217
American Express
AXP
$227B
| $103M | 0.09% |
616,913
+554,377
| +886% | +$92.7M |
|
218
CALL
Adobe
ADBE
$109B
| $103M | 0.09% |
178,800
-21,400
| -11% | -$13.5M |
|
219
Carvana
CVNA
$76.9B
| $102M | 0.09% |
1,697,025
+7,785
| +0.5% | +$518K |
|
220
PUT
JPMorgan Chase
JPM
$935B
| $102M | 0.09% |
621,400
-193,000
| -24% | -$30.3M |
|
221
Capital One
COF
$134B
| $101M | 0.09% |
624,300
+269,961
| +76% | +$44.1M |
|
|
XYZ
222
Block Inc
XYZ
$49.4B
| $101M | 0.09% |
420,941
-1,261,713
| -75% | -$324M |
|
223
CALL
Moderna
MRNA
$57.9B
| $101M | 0.09% |
261,900
-100,800
| -28% | -$37.2M |
|
224
Goldman Sachs
GS
$303B
| $100M | 0.09% |
265,004
+58,639
| +28% | +$22.9M |
|
225
Zimmer Biomet
ZBH
$19.3B
| $100M | 0.09% |
704,007
-258,141
| -27% | -$38M |
|
Similar funds
David Shaw's Q3 2021 Portfolio in Review
As of Q3 2021, David Shaw held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
David Shaw withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, David Shaw opened a new position in Sea Limited worth $206M.
- David Shaw's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- David Shaw added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- David Shaw's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- David Shaw fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- David Shaw's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- David Shaw opened 915 new positions and closed 695 in Q3 2021.
- David Shaw's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.